Clinical trial
Safety and Protective Efficacy of Repeated Controlled Human Schistosoma Mansoni Infection
NCT05085470 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Protective Efficacy of Repeated Controlled Human Schistosoma Mansoni Infection
- Lead sponsor
- Leiden University Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 29, 2021
- Completion date
- January 11, 2023
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
schistosoma mansoni, schistosomiasis